← Browse by Condition
Medical Condition
amblyopia
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for amblyopia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — amblyopia Clinical Trials
How many clinical trials are currently recruiting for amblyopia?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for amblyopia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for amblyopia?
amblyopia research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a amblyopia clinical trial?
Eligibility criteria for amblyopia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 2
Top Sponsors
2 trials
2 trials
1 trial
1 trial
Recruiting Clinical Trials
NCT06380517 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Enrollment
238 pts
Location
United States
Sponsor
Jaeb Center for Health Researc...
NCT07281742
Recruiting
Amblyopia Treatment for Children Aged 8 to 12 Years
Enrollment
30 pts
Location
United States
Sponsor
Retina Foundation of the South...
NCT05439200
Recruiting
Video Treatment for Amblyopia
Enrollment
44 pts
Location
United States
Sponsor
Retina Foundation of the South...
NCT06429280
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc...
NCT05393739
Recruiting
Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study
Enrollment
30 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology